Dr. Geoffrey Oxnard on Managing Acquired Resistance to EGFR Inhibitor Therapy (and Probably Crizotinib, Too)
6 min•4 mars 2013
Dr. Geoffrey Oxnard, Dana Farber Cancer Institute, describes a wide range of options for best managing patients with advanced NSCLC who experience acquired resistance, the progression of cancer after a good initial response to a targeted therapy.
Fler avsnitt av GRACEcast Pancreatic Cancer Audio
Visa alla avsnitt av GRACEcast Pancreatic Cancer AudioGRACEcast Pancreatic Cancer Audio med cancerGRACE - H. Jack West, MD finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.